Madeleine Williams
Stock Analyst at Canaccord Genuity
(0.15)
# 4,372
Out of 4,478 analysts
79
Total ratings
33.3%
Success rate
-14.7%
Average return
Main Sectors:
Stocks Rated by Madeleine Williams
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASX: MYX Mayne Pharma Group Limited | Maintained: Buy | $6.10 → $3.83 | $2.81 | +36.30% | 3 | Jul 5, 2026 | |
| ASX: IMR Imricor Medical Systems, Inc. | Maintained: Buy | $2.28 | $1.96 | +16.62% | 7 | Jul 4, 2026 | |
| ASX: NEU Neuren Pharmaceuticals Limited | Maintained: Buy | $24.00 | $16.44 | +46.03% | 6 | Jun 29, 2026 | |
| ASX: CGS Cogstate Limited | Maintained: Buy | $3.15 | $2.83 | +11.31% | 5 | Jun 11, 2026 | |
| ASX: ATH Alterity Therapeutics Limited | Maintained: Buy | $0.01 → $0.95 | $0.71 | +33.80% | 4 | Jun 10, 2026 | |
| ASX: PYC PYC Therapeutics Limited | Maintained: Buy | $2.84 | $1.55 | +83.82% | 3 | Jun 6, 2026 | |
| ASX: CU6 Clarity Pharmaceuticals Ltd | Maintained: Buy | $8.41 | $2.54 | +231.10% | 11 | May 26, 2026 | |
| ASX: SNT Syntara Limited | Maintained: Buy | $0.15 | $0.025 | +500.00% | 8 | May 23, 2026 | |
| ASX: EBR EBR Systems, Inc. | Maintained: Buy | $2.27 | $0.415 | +446.99% | 11 | May 20, 2026 | |
| ASX: PME Pro Medicus Limited | Maintained: Buy | $180.82 → $168.62 | $212.94 | -20.81% | 3 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $0.80 → $0.27 | $0.295 | -8.47% | 2 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $0.14 | $0.022 | +536.36% | 5 | May 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3.23 | $2.07 | +56.04% | 4 | Apr 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $1.27 → $0.40 | $0.054 | +640.74% | 3 | Mar 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $32.84 → $27.90 | $10.23 | +172.86% | 2 | Mar 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $27.33 → $27.41 | $17.53 | +56.36% | 2 | Oct 15, 2025 |
Mayne Pharma Group Limited
Jul 5, 2026
Maintained: Buy
Price Target: $6.10 → $3.83
Current: $2.81
Upside: +36.30%
Imricor Medical Systems, Inc.
Jul 4, 2026
Maintained: Buy
Price Target: $2.28
Current: $1.96
Upside: +16.62%
Neuren Pharmaceuticals Limited
Jun 29, 2026
Maintained: Buy
Price Target: $24.00
Current: $16.44
Upside: +46.03%
Cogstate Limited
Jun 11, 2026
Maintained: Buy
Price Target: $3.15
Current: $2.83
Upside: +11.31%
Alterity Therapeutics Limited
Jun 10, 2026
Maintained: Buy
Price Target: $0.01 → $0.95
Current: $0.71
Upside: +33.80%
PYC Therapeutics Limited
Jun 6, 2026
Maintained: Buy
Price Target: $2.84
Current: $1.55
Upside: +83.82%
Clarity Pharmaceuticals Ltd
May 26, 2026
Maintained: Buy
Price Target: $8.41
Current: $2.54
Upside: +231.10%
Syntara Limited
May 23, 2026
Maintained: Buy
Price Target: $0.15
Current: $0.025
Upside: +500.00%
EBR Systems, Inc.
May 20, 2026
Maintained: Buy
Price Target: $2.27
Current: $0.415
Upside: +446.99%
Pro Medicus Limited
May 12, 2026
Maintained: Buy
Price Target: $180.82 → $168.62
Current: $212.94
Upside: -20.81%
May 12, 2026
Downgraded: Hold
Price Target: $0.80 → $0.27
Current: $0.295
Upside: -8.47%
May 3, 2026
Maintained: Buy
Price Target: $0.14
Current: $0.022
Upside: +536.36%
Apr 14, 2026
Maintained: Buy
Price Target: $3.23
Current: $2.07
Upside: +56.04%
Mar 13, 2026
Maintained: Buy
Price Target: $1.27 → $0.40
Current: $0.054
Upside: +640.74%
Mar 2, 2026
Maintained: Buy
Price Target: $32.84 → $27.90
Current: $10.23
Upside: +172.86%
Oct 15, 2025
Maintained: Buy
Price Target: $27.33 → $27.41
Current: $17.53
Upside: +56.36%